The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(6-(1-methyl-1H-imidazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-N-(2,2,2-trifluoroethyl)thiophene-2-carboxamide ID: ALA4547786
PubChem CID: 59603981
Max Phase: Preclinical
Molecular Formula: C17H13F3N6OS
Molecular Weight: 406.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cnc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)c1
Standard InChI: InChI=1S/C17H13F3N6OS/c1-25-6-13(23-9-25)11-3-21-15-12(4-24-26(15)5-11)10-2-14(28-7-10)16(27)22-8-17(18,19)20/h2-7,9H,8H2,1H3,(H,22,27)
Standard InChI Key: SYTUPDMBDULQBO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
29.9389 -10.7638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9389 -11.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6442 -11.9855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6442 -10.3511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3495 -10.7638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3494 -11.5820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1276 -11.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6086 -11.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1277 -10.5111 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3817 -12.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9014 -13.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3816 -13.9385 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.1589 -13.6861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1589 -12.8689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8200 -14.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7346 -14.9791 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5666 -13.8340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2277 -14.3144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9742 -13.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6354 -14.4623 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0597 -13.1693 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.6787 -13.5662 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.2279 -10.3586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1401 -9.5462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3402 -9.3786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9337 -10.0876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4823 -10.6932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1212 -10.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
7 10 1 0
13 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
27 23 2 0
1 23 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.39Molecular Weight (Monoisotopic): 406.0824AlogP: 3.15#Rotatable Bonds: 4Polar Surface Area: 77.11Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.90CX Basic pKa: 5.43CX LogP: 2.38CX LogD: 2.38Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.56Np Likeness Score: -1.95
References 1. Sloman DL, Noucti N, Altman MD, Chen D, Mislak AC, Szewczak A, Hayashi M, Warren L, Dellovade T, Wu Z, Marcus J, Walker D, Su HP, Edavettal SC, Munshi S, Hutton M, Nuthall H, Stanton MG.. (2016) Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties., 26 (17): [PMID:27491711 ] [10.1016/j.bmcl.2016.02.003 ]